Metastatic Breast Cancer News from 2021 ESMO
The European Society for Medical Oncology (ESMO) was held virtually from September 16-21, 2021. Links to MBC-related news from this conference are found below....
Read MoreTheragnostics
The term “theragnostics” (also called “theranostics”) is a combination of two words: therapy and diagnostics. This technology allows...
Read MoreSpotlight on the Tigerlily Foundation & Breast Cancer Racial Disparities
Our newest Metastatic Trial Search partner is the Tigerlily Foundation. Tigerlily educates, advocates for, empowers, and supports young women diagnosed with...
Read MoreHealth Insurance for MBC
A cancer diagnosis is a life-changing event. It not only impacts health, it can also affect every aspect of one’s life, including finances, insurance,...
Read MoreAtezolizumab Immunotherapy Is Withdrawn From FDA-Approval Process
Atezolizumab (Tecentriq®) was the first FDA-approved immunotherapy for treating locally advanced or metastatic triple-negative breast cancer (TNBC). It is for...
Read MoreMetastatic Trial Search: New Features
Metastatic Trial Search provides clinical trial information in a patient-friendly format that makes it easy to understand what a trial is studying, who can...
Read MoreMetastatic Breast Cancer News from ASCO 2021
The American Society of Clinical Oncology’s (ASCO) annual meeting was held online from June 4 through June 8, 2021. During the conference, researchers...
Read MoreFDA Fast Track
FDA Fast Track is a program to accelerate the development, review, and approval of new drugs to fill an unmet medical need, such as treatment for metastatic...
Read MoreCell-Based Therapies: A Type of Immunotherapy for MBC
Immunotherapy is a type of treatment for MBC that increases the immune system’s ability to kill cancer cells. Many immunotherapy treatments are drugs. However,...
Read MoreSEARCH OUR SITE
for past articles or specific information.